logo
Plus   Neg
Share
Email

Brink's Company Adjusts FY19 Guidance To Reflect Impact Of Currency Translation

The Brink's Company (BCO) updated its full-year 2019 non-GAAP guidance to reflect higher-than-expected negative currency translation. Full-year non-GAAP guidance now includes revenue growth of 8 percent (7 percent organic) to $3.7 billion (updated from prior guidance of $3.75 million). Operating profit growth is projected at approximately 14 percent to a range between $385 million and $405 million (revised from prior midpoint of $415 million). Earnings per share is anticipated to grow 16 percent to a range between $3.90 and $4.10 (versus prior midpoint of $4.20 per share). Analysts polled by Thomson Reuters expect the company to report profit per share of $3.96 on revenue of $3.72 billion. Analysts' estimates typically exclude special items.

For the third-quarter, non-GAAP operating profit rose 7 percent to $102 million. Earnings per share was $1.05, up 11 percent from prior year. On average, four analysts polled by Thomson Reuters expected the company to report profit per share of $1.04, for the quarter.

Third-quarter non-GAAP revenue increased 8 percent year-on-year to $925 million. Analysts expected revenue of $931.07 million, for the quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Video streaming giant Netflix said it will donate 1 million euros to Audiens, the social protection group of the French cultural sector, to help launch a COVID-19 emergency relief fund to support workers in the French television and cinema industry. Netflix and Audiens said they have created the new COVID-19 Film and TV Emergency Relief Fund to help the hardest hit workers in the industry. Major U.S. retail container ports are estimated to report a five-year low for imports in March as consumer demand has been impacted with millions of Americans out of work amid the coronavirus (COVID-19) outbreak, according to a report by the National Retail Federation or NRF. The U.S. Food and Drug Administration has issued warning letters to three sellers of fraudulent COVID-19 products. There are currently no approved preventatives or treatments for COVID-19, the FDA said in a statement.
Follow RTT
>